Observational Study of Swallowing Exercises in Head and Neck Cancer

This observational study is looking at how well people with head and neck cancer that has spread (metastatic) stick to swallowing exercises. Researchers will use blood tests to look at cytokines (proteins related to the immune system) to see if they affect side effects or future disease risk. Questionnaires will help understand why people do or don't follow these exercises after radiation. The study aims to understand if your perceptions about your illness, your social support, and how you cope affect how well you do these exercises. You may be eligible if you are receiving radiation for certain head and neck cancers, including HPV-related oropharyngeal cancer, and are at least 18 years old. The study is currently unclear on its recruitment status.

Study design
This is an observational study with a planned enrollment of 471 participants. It is not a treatment trial, but rather observes participants over time.
What's involved
You would provide blood samples before and 6 months after radiation therapy. You would also complete questionnaires at home, in clinic, or online before radiation and within 14 days of blood sample collection.
Compensation
Not stated in the trial record.
Follow-up
Participants are followed periodically for up to 2 years after the study's completion.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03010150

Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer

Recruiting
Not specifiedAges 18+Observational
M.D. Anderson Cancer Center
~471 participants
Updated 2026-04-15 on ClinicalTrials.gov
What's tested:Biospecimen CollectionQuestionnaire Administration

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adherence to swallowing exercises
Measured over Up to 6 months
+2 more outcomes measured
Carcinoma of Unknown Primary
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Metastatic Head and Neck Carcinoma
Metastatic Malignant Neoplasm in the Uterine Cervix
Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Stage I Hypopharyngeal Carcinoma AJCC v8
Stage I Nasopharyngeal Carcinoma AJCC v8
Stage II Hypopharyngeal Carcinoma AJCC v8
Stage II Laryngeal Cancer AJCC v8
Stage II Nasopharyngeal Carcinoma AJCC v8
Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage III Hypopharyngeal Carcinoma AJCC v8
Stage III Laryngeal Cancer AJCC v8
Stage III Nasopharyngeal Carcinoma AJCC v8
Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IV Hypopharyngeal Carcinoma AJCC v8
Stage IV Laryngeal Cancer AJCC v8
Stage IV Nasopharyngeal Carcinoma AJCC v8
Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVA Hypopharyngeal Carcinoma AJCC v8
Stage IVA Laryngeal Cancer AJCC v8
Stage IVA Nasopharyngeal Carcinoma AJCC v8
Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Stage IVB Hypopharyngeal Carcinoma AJCC v8
Stage IVB Laryngeal Cancer AJCC v8
Stage IVB Nasopharyngeal Carcinoma AJCC v8
Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8

NCT03010150

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • M D Anderson Cancer Center

    Houston, Texasstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Eileen H Shinn · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Eileen H. Shinn
Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Are dispositioned to receive radiation with curative intent for nasopharyngeal, oropharyngeal, hypopharyngeal, laryngeal, or an unknown primary cancer with cervical metastases
Are stage II-IVb for non- human papillomavirus (HPV)- related oropharyngeal cancer
Have HPV- related oropharynx cancer that is T1, have nodal involvement with no distant metastasis or have HPV- related oropharynx cancer that is at least T2 with no distant metastasis
Are stage II-IVb for laryngeal cancer
Are stage I-IVb for hypopharyngeal
Are stage I-IVb for nasopharyngeal cancer
Have stage I-III unknown primary cancer with cervical

Exclusion

Have other cancer diagnoses, except non-melanoma skin cancer
Had treatment for previous head and neck cancer or radiation to the head and neck
Have a history of previous head and neck surgery (excluding biopsy and/or tonsillectomy and/or tracheotomy)
Have a current oropharyngeal dysphagia unrelated to cancer diagnosis (e.g., dysphagia due to underlying neurogenic disorder)
  • Adherence to swallowing exercisesUp to 6 months

    The primary analytic approach is to use linear mixed models to determine whether illness perceptions significantly predict adherence 6 months. The study will estimate and test the illness perception subscale scores' relationship to adherence using a linear mixed model. In the model, the dependent variable is the patient's self-reported adherence score and independent variables include illness perception, follow-up assessment time point and other covariates such as demographic and medical variables, depression, pain, fatigue, emotional coping, objective coping, appraisal of coping, stress, and lack of social well-being.

  • Illness perceptionsUp to 6 months

    The study's statistical tool is mediation analysis: the independent variables are the sickness behaviors (depression, fatigue, pain); the mediators are the cytokine levels, and the outcome variable is illness perception. The study will test the mediator effects based on the product of coefficients method, rather than the classical Baron \& Kenny causal steps tests, since the former approach has better statistical power. The study will conduct both single-mediator analysis for each of the mediators, and multiple-mediator analysis with all mediators in the mediating process

  • Effect of social support on copingUp to 6 months

    The moderating effect of social support on coping and appraisal of coping is the statistical equivalent of testing the two-way interaction between these variables and the social support variable. Multivariate linear regression will be used, in which the dependent variable is appraisal of coping at 6 months follow-up, and independent variables include the emotion-focused coping and action-focused sub scales, social support, and their two-way interactions. In the regression, the study will control for baseline variables. In addition, we will also apply the linear mixed model to investigate the moderating effect of these variables longitudinally. The mixed model naturally accounts for the correlation of repeated measures at baseline and 6 months follow-up.